Betibeglogene Autotemcel gene therapy for Non–beta0/beta0 Genotype beta-thalassemia.
13 Feb, 2022 | 21:46h | UTCBetibeglogene Autotemcel Gene Therapy for Non–β0/β0 Genotype β-Thalassemia – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
Visual Abstract: Betibeglogene Autotemcel Gene Therapy for Non–β0/β0 Genotype β-Thalassemia. https://t.co/2GOCGxrruv pic.twitter.com/zLvuuuByXN
— NEJM (@NEJM) February 8, 2022